Pfizer (PFE) Misses Q4 EPS by 3c; Issues Lackluster Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
Revenue Growth %: -1.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -1.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $13.6 billion versus the consensus estimate of $13.64 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.57. Pfizer sees FY2017 revenue of $52-54 billion, versus the consensus of $54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
